CMAJ • January 30, 2007; 176 (3). doi:10.1503/cmaj.060825.
© 2007 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rayson, D.
Right arrow Articles by Dewar, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rayson, D.
Right arrow Articles by Dewar, R.
Related Collections
Right arrow Breast Cancer
Right arrow Wait Times
Right arrowRelated Articles

Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04

Daniel Rayson, Nathalie Saint-Jacques, Tallal Younis, Jason Meadows and Ron Dewar

From the Faculty of Medicine, Dalhousie University, and the Cancer Care Program, Capital District Health Authority (Rayson, Younis, Meadows); and the Surveillance and Epidemiology Unit, Cancer Care Nova Scotia (Saint-Jacques, Dewar), Halifax, NS


Figure 119
View larger version (31K):
[in this window]
[in a new window]

  		Fig. 1: Case selection and exclusion criteria for 2 cohorts of patients with newly diagnosed breast cancer referred to a Nova Scotia cancer centre. Some cases may have been excluded for more than one reason.

 

Figure 219
View larger version (17K):
[in this window]
[in a new window]

  		Fig. 2: Elapsed times between care intervals for women with newly diagnosed invasive breast cancer referred to a Nova Scotia cancer centre between Sept. 1, 1999, and Sept. 1, 2000 (cohort 1) and between Sept. 1, 2003, and Sept. 1, 2004 (cohort 2). Median number of days (unadjusted for cofactors) with first and third quartiles (cohorts combined) are shown in diamonds. Geometric mean number of days (adjusted for cofactors) with 95% confidence intervals (cohort comparison) are shown below each care interval. The significance in the differences in elapsed days observed between cohort periods is indicated by p values.

 

View this table:
[in this window]
[in a new window]

  		Table 1.

 

View this table:
[in this window]
[in a new window]

  		Table 2.

 

View this table:
[in this window]
[in a new window]

  		Table 3.